The future of dentistry is here, where the latest evidence-based concepts are utilized to further improve your health from both a dental and medical perspective.
A cutting-edge chairside test that detects sub-clinical inflammation and
real-time periodontal breakdown on a cellular level before any clinical signs are evident!
Periodontal disease has long been identified as a rising epidemic in the United States, with nearly 50% of adult Americans showing varying degrees of gum disease which can ultimately lead to tooth loss. Furthermore, enzymes found in the saliva of patients with periodontal conditions have been linked with many chronic systemic diseases.
The traditional dental approach is to provide treatment after the signs and symptoms of gum disease are present. SalivaScore’s patented oral biomarker test detects a measure of aMMP-8, which is the most prevalent cellular biomarker associated with oral and systemic tissue breakdown and destruction around teeth and implants.
The science behind the aMMP-8 biomarker’s significance has been cited in over 1000 medical and 400 dental publications over the last 15 years.
This test is especially important since most “gum disease” does not hurt and is invisible until it is in the advanced stages.
With SalivaScore, the new paradigm is to prevent periodontal conditions “before there is damage” and to be able to predict or identify those high-risk patients that are likely to experience rapid disease progression.
This early detection and prevention screening provides personalized information on the risks for developing periodontal disease and associated medical conditions of your mouth based on a sample of your saliva.
Your SalivaScore analysis shows if you have low, elevated or highly elevated levels of aMMP-8. This individualized salivary cellular biomarker analysis indicates the real-time breakdown of collagen and expected rate of disease progression. Personalized oral medicine is now possible.
Clinicians can now tailor customized plans focused on preventive/predictive strategies which will address oral inflammation, tooth loss and systemic diseases
The future of dentistry is here, where the latest evidence-based concepts are utilized to further improve your health from both a dental and medical perspective.
A cutting-edge chairside test that detects sub-clinical inflammation and real-time periodontal breakdown on a cellular level before any clinical signs are evident!
The traditional dental approach is to provide treatment after the signs and symptoms of gum disease are present. SalivaScore’s patented oral biomarker test detects a measure of aMMP-8, which is the most prevalent cellular biomarker associated with oral and systemic tissue breakdown and destruction around teeth and implants. The science behind the aMMP-8 biomarker’s significance has been cited in over 1000 medical and 400 dental publications over the last 15 years.
With SalivaScore, the new paradigm is to prevent periodontal conditions “before there is damage” and to be able to predict or identify those high-risk patients that are likely to experience rapid disease progression.
This test is especially important since most “gum disease” does not hurt and is invisible until it is in the advanced stages.
With early detection, we have a better opportunity to apply more conservative and cost-effective management strategies. This approach can save patients a considerable amount of time and money by avoiding the disease altogether.
Periodontal disease has long been identified as a rising epidemic in the United States, with nearly 50% of adult Americans showing varying degrees of gum disease which can ultimately lead to tooth loss. Furthermore, enzymes found in the saliva of patients with periodontal conditions have been linked with many chronic systemic diseases.
This early detection and prevention screening provides personalized information on the risks for developing periodontal disease and associated medical conditions of your mouth based on a sample of your saliva.
Your SalivaScore analysis shows if you have low, elevated or highly elevated levels of aMMP-8. This individualized salivary cellular biomarker analysis indicates the real-time breakdown of collagen and expected rate of disease progression. Personalized oral medicine is now possible.
Clinicians can now tailor customized plans focused on preventive/predictive strategies which will address oral inflammation, tooth loss and systemic diseases
Since this test measures in real-time, we want to make sure your immediate
pre-appointment behaviors do not negatively impact your results.
Since this test measures in real-time, we want to make sure your immediate pre-appointment behaviors do not negatively impact your results.
Find a practice nearest you to learn more and schedule an appointment!
Kopman Periodontics & Dental Implant Solutions
(631) 351-3444 | 999 Walt Whitman Road Suite 303, Melville, NY 11747
Leading Edge Periodontics & Dental Implants
(508) 586-6002 | 682 Depot Street, Suite A, North Easton, MA 02356
West Bridgewater Dental
(508) 586-0023 | 399 West Center Street, West Bridgewater, MA 02379
Find a practice nearest you to learn more and schedule an appointment!
Kopman Periodontics &
Dental Implant Solutions
(631) 351-3444
999 Walt Whitman Road Suite 303,
Melville, NY 11747
Leading Edge Periodontics
& Dental Implants
(508) 586-6002
682 Depot Street, Suite A
North Easton, MA 02356
West Bridgewater Dental
(508) 586-0023
399 West Center Street,
West Bridgewater, MA 02379